Literature DB >> 24905021

The effect of ischemia/reperfusion on the kidney graft.

Julia Menke1, Daniel Sollinger, Beate Schamberger, Uwe Heemann, Jens Lutz.   

Abstract

PURPOSE OF REVIEW: Ischemia/reperfusion injury is an unavoidable companion after kidney transplantation and influences short-term as well as long-term graft outcome. Clinically ischemia/reperfusion injury is associated with delayed graft function, graft rejection, and chronic graft dysfunction. Ischemia/reperfusion affects many regulatory systems at the cellular level as well as in the renal tissue that eventually result in a distinct inflammatory reaction of the kidney graft. RECENT
FINDINGS: Underlying factors include energy metabolism, cellular changes of the mitochondria and cellular membranes, initiation of different forms of cell death-like apoptosis and necrosis together with a recently discovered mixed form termed necroptosis. Chemokines and cytokines together with other factors promote the inflammatory response leading to activation of the innate immune system as well as the adaptive immune system. If the inflammatory reaction continues within the graft tissue, a progressive interstitial fibrosis develops that impacts long-term graft outcome.
SUMMARY: It is of particular importance in kidney transplantation to understand the underlying mechanisms and effects of ischemia/reperfusion on the graft as this knowledge also opens strategies to prevent or treat ischemia/reperfusion injury after transplantation in order to improve graft outcome.

Entities:  

Mesh:

Year:  2014        PMID: 24905021     DOI: 10.1097/MOT.0000000000000090

Source DB:  PubMed          Journal:  Curr Opin Organ Transplant        ISSN: 1087-2418            Impact factor:   2.640


  33 in total

1.  Transplantation-Induced Ischemia-Reperfusion Injury Modulates Antigen Presentation by Donor Renal CD11c+F4/80+ Macrophages through IL-1R8 Regulation.

Authors:  Sistiana Aiello; Manuel Alfredo Podestà; Pamela Y Rodriguez-Ordonez; Francesca Pezzuto; Nadia Azzollini; Samantha Solini; Camillo Carrara; Marta Todeschini; Federica Casiraghi; Marina Noris; Giuseppe Remuzzi; Ariela Benigni
Journal:  J Am Soc Nephrol       Date:  2020-01-27       Impact factor: 10.121

2.  Markers of Endothelial-to-Mesenchymal Transition: Evidence for Antibody-Endothelium Interaction during Antibody-Mediated Rejection in Kidney Recipients.

Authors:  Yi-Chun Xu-Dubois; Julie Peltier; Isabelle Brocheriou; Caroline Suberbielle-Boissel; Arjang Djamali; Shannon Reese; Nuala Mooney; Zela Keuylian; Julien Lion; Nacéra Ouali; Pierre P Levy; Chantal Jouanneau; Eric Rondeau; Alexandre Hertig
Journal:  J Am Soc Nephrol       Date:  2015-05-20       Impact factor: 10.121

3.  Complement Inhibitor CRIg/FH Ameliorates Renal Ischemia Reperfusion Injury via Activation of PI3K/AKT Signaling.

Authors:  Chao Hu; Long Li; Peipei Ding; Ling Li; Xiaowen Ge; Long Zheng; Xuanchuan Wang; Jina Wang; Weitao Zhang; Na Wang; Hongyu Gu; Fan Zhong; Ming Xu; Ruiming Rong; Tongyu Zhu; Weiguo Hu
Journal:  J Immunol       Date:  2018-11-14       Impact factor: 5.422

4.  Sex and the single transplanted kidney.

Authors:  Sanjeev Noel; Niraj M Desai; Abdel Rahim A Hamad; Hamid Rabb
Journal:  J Clin Invest       Date:  2016-04-18       Impact factor: 14.808

Review 5.  Epigenetics in Kidney Transplantation: Current Evidence, Predictions, and Future Research Directions.

Authors:  Valeria R Mas; Thu H Le; Daniel G Maluf
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

Review 6.  Update on ischemia-reperfusion injury in kidney transplantation: Pathogenesis and treatment.

Authors:  Maurizio Salvadori; Giuseppina Rosso; Elisabetta Bertoni
Journal:  World J Transplant       Date:  2015-06-24

7.  Effect of ozone oxidative preconditioning on oxidative stress injury in a rat model of kidney transplantation.

Authors:  Tao Qiu; Zhi-Shun Wang; Xiu-Heng Liu; Hui Chen; Jiang-Qiao Zhou; Zhi-Yuan Chen; Min Wang; Guan-Jun Jiang; Lei Wang; Gang Yu; Long Zhang; Ye Shen; Lu Zhang; Li He; Hua-Xin Wang; Wen-Jing Zhang
Journal:  Exp Ther Med       Date:  2017-03-08       Impact factor: 2.447

8.  Deficiency of cold-inducible ribonucleic acid-binding protein reduces renal injury after ischemia-reperfusion.

Authors:  Cindy Cen; Weng-Lang Yang; Hao-Ting Yen; Jeffrey M Nicastro; Gene F Coppa; Ping Wang
Journal:  Surgery       Date:  2016-06-03       Impact factor: 3.982

Review 9.  Vascularized composite allotransplantation: current standards and novel approaches to prevent acute rejection and chronic allograft deterioration.

Authors:  Maximilian Kueckelhaus; Sebastian Fischer; Midas Seyda; Ericka M Bueno; Mario A Aycart; Muayyad Alhefzi; Abdallah ElKhal; Bohdan Pomahac; Stefan G Tullius
Journal:  Transpl Int       Date:  2015-09-14       Impact factor: 3.782

10.  Gypenoside attenuates renal ischemia/reperfusion injury in mice by inhibition of ERK signaling.

Authors:  Qifa Ye; Y I Zhu; Shaojun Ye; Hong Liu; Xingguo She; Ying Niu; Yingzi Ming
Journal:  Exp Ther Med       Date:  2016-01-29       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.